September 26, 2017

AbbVie Statement on Drug Pricing

Share to Facebook Share to Twitter Share to Linkedin Email Sign Up for Alerts Print
Media Statement

AbbVie Statement on Drug Pricing

Statements made by AbbVie management about drug pricing have been incorrectly characterized in multiple sources. We evaluate specific pricing decisions on an annual basis, with careful consideration of a variety of factors.  For 2018, AbbVie will take one single digit price increase and will continue to act responsibly with respect to drug pricing.